Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01709734 |
| Title | A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer |
| Acronym | ARMOR2 |
| Recruitment | Terminated |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Tokai Pharmaceuticals |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CAN |